Rare Biomarkers Specimen Collection And Stabilization Market Size, Share, & Trends Analysis Report By Biomarker & Product (Tubes, Isolation Kits), By End Use, By Region, And Segment Forecasts, 2020 - 2027
- Report ID: GVR-4-68038-459-8
- Number of Pages: 209
- Format: Electronic (PDF)
- Historical Range: 2016 - 2018
- Industry:Healthcare
Market Segmentation
- Rare Biomarkers Specimen Collection & Stabilization Biomarker & Product Outlook (Revenue, USD Million, 2015 - 2027)
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Rare Biomarkers Specimen Collection & Stabilization End-use Outlook (Revenue, USD Million, 2015 - 2027)
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- Rare Biomarkers Specimen Collection & Stabilization Regional Outlook (Revenue, USD Million, 2015 - 2027)
- North America
- 北美罕见的生物标记样本收集& Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- 北美罕见的生物标记样本收集& Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- U.S.
- U.S. Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- U.S. Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- U.S. Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Canada
- Canada Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Canada Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- Canada Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- 北美罕见的生物标记样本收集& Stabilization Market, By Biomarker & Product
- Europe
- Europe Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Europe Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- U.K.
- U.K. Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- U.K. Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- U.K. Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Germany
- 德国罕见生物标记样本收集和刺ilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- 德国罕见生物标记样本收集和刺ilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- 德国罕见生物标记样本收集和刺ilization Market, By Biomarker & Product
- France
- France Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- France Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- France Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Spain
- Spain Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Spain Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- Spain Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Italy
- Italy Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Italy Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- Italy Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Netherlands
- Netherlands Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Netherlands Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- Netherlands Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Europe Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Asia Pacific
- Asia Pacific Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Asia Pacific Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- China
- China Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- China Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- China Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Japan
- Japan Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Japan Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- Japan Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- India
- India Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- India Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- India Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- South Korea
- South Korea Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- South Korea Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- South Korea Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Singapore
- Singapore Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Singapore Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- Singapore Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Australia
- Australia Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Australia Rare Biomarkers Specimen Collection & Stabilization Market, End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- Australia Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- South East Asia
- South East Asia Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- South East Asia Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- South East Asia Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Asia Pacific Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Latin America
- Latin America Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Latin America Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- Brazil
- Brazil Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Brazil Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- Brazil Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Latin America Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Middle East & Africa (MEA)
- MEA Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- MEA Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- South Africa
- South Africa Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- Systems
- By Specimen Type
- Serum/Plasma
- Others
- By Nucleic Acid & Other Biomolecules
- RNA
- DNA
- Others
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Screening
- Treatment Monitoring
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- Circulating Cell Free RNA (ccfRNA) / miRNA
- By Product
- Isolation Kits & Reagents
- Blood Collection Tubes
- By Application
- NIPT
- Oncology
- Research
- Diagnostics
- Transcriptomics
- Pharmacogenomics
- Transplant Rejection
- Population Screening
- Cardiovascular Diseases
- Other Applications
- By Product
- South Africa Rare Biomarkers Specimen Collection & Stabilization Market, By End Use
- Research
- Research Labs/CROs
- Academic Institutes
- Diagnostics
- Laboratories
- Hospitals
- Prenatal Clinics
- Research
- South Africa Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- MEA Rare Biomarkers Specimen Collection & Stabilization Market, By Biomarker & Product
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- 乐鱼体育手机网站入口
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2016 to 2027
- Market estimates and forecast for product segments up to 2027
- Regional market size and forecast for product segments up to 2027
- Market estimates and forecast for application segments up to 2027
- Regional market size and forecast for application segments up to 2027
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report -free of charge——包括购买单独的部分或计谋ntry-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us nowto get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.
